None listed
Conditions
Interventions
Intervention1: Treatment oil 1-A123: Take approximately 7.5 ml of oil on your palm and apply to one half of the scalp. And take approximately 7.5 ml of oil on your palm the second time and apply to th
Sponsors
Bajaj Consumer Care Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Female subjectsââ?¬• in general good health. 2.Subjects in the age group 18-45 years (both the ages inclusive). 3.Subjects complaining of hair fall and damage. 4.Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol. 5.Hair density of >100 and 6.Female Subjects falling under Grade 3 - Grade 6 of hair loss severity grade evaluated as per photo numerical 10-point scale (Linear scale for assessment purpose-In Use Scale).
Exclusion criteria
Exclusion criteria: 1.Subjects who have undergone hair growth treatment within 3 months before screening into the study. 2.Subjects having any active scalp disease which may interfere in the study ââ?¬â?? dermatologistââ?¬•s judgement. 3.Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study. 4.Subjects who have history of alcoholism, smoking, crash dieting and/ or psychiatric disorder including trichotillomania. 5.Subjects who have had hair transplant, who have taken pharmaceutical product which cause hirsutism (ex. phenytoin) and finesteride for androgenic alopecia, under medical treatment for hair problems. 6.A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products. 7.Subjects on oral medications, undergoing any chemical hair salon treatment-straightening / perming / colour which will compromise the study. 8.Subjects who are pregnant or lactating or nursing as established with medical history. 9.Menopausal female subjects as determined by medical history. 10.Subjects with chronic illness which may influence the cutaneous state. 11.Subjects participating in other similar cosmetic or therapeutic trial within last three months. 12.Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Significant improvement in hair growth rate and hair density. 2.Significant improvement in hair thickness. 3.Significant reduction in hair fall count. 4.Significant improvement in hair thinning. 5.Significant improvement in hair quality.Timepoint: At Day30, Day60, Day90 in comparison to baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the product safety by dermatologist assessment.Timepoint: At Day30, Day60, Day90 in comparison to baseline. | — |
Countries
India
Contacts
Public ContactDr Mukesh Ramnane
MS Clinical Research Pvt Ltd
Outcome results
None listed